|
End-of-day quote
NSE India S.E.
28/10/2026
|
5-day change | 1st Jan Change | ||
| 862.25 INR | +1.33% |
|
-1.26% | +14.74% |
| 25/09 | Supriya Lifescience Limited Approves Final Dividend for the Financial Year Ended March 31, 2026 | CI |
| 14/08 | Supriya Lifescience Limited, Q1 2027 Earnings Call, Aug 14, 2026 |
| Market Cap | 6.94TCr 73Cr 65Cr 60Cr 55Cr 102.27Cr 103.5Cr 722.65Cr 287.84Cr 3.63TCr 273.43Cr 267.66Cr 12TCr | P/E 2027 * |
29.2x | P/E 2028 * | 22.2x |
|---|---|---|---|---|---|
| Enterprise Value | 6.94TCr 73Cr 65Cr 60Cr 55Cr 102.27Cr 103.5Cr 722.65Cr 287.84Cr 3.63TCr 273.43Cr 267.66Cr 12TCr | EV / Sales 2027 * |
6.99x | EV / Sales 2028 * | 5.59x |
| Free-Float |
28.72% | Yield 2027 * |
-
| Yield 2028 * | - |
NSE India S.E.INR
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| SUPRIYA | End-of-day quote | |
Bombay S.E.
| SUPRIYA | Delayed |
Last Transcript: Supriya Lifescience Limited
| 1 day | +1.33% | ||
| 1 week | -1.26% | ||
| Current month | -9.26% | ||
| 1 month | -12.48% | ||
| 3 months | +2.05% | ||
| 6 months | +22.40% | ||
| Current year | +14.74% |
| 1 week | 801 |  | 879.2 |
| 1 month | 801 | | 1,019.8 |
| Current year | 545.5 | | 1,085 |
| 1 year | 545.5 | | 1,085 |
| 3 years | 239.8 | | 1,085 |
| 5 years | 170.15 | | 1,085 |
| 10 years | 170.15 | | 1,085 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 35 | 01/08/2024 | |
| Chief Executive Officer | 36 | 01/08/2024 | |
| Director of Finance/CFO | - | 23/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 26/03/2008 | |
| Director/Board Member | 41 | 01/06/2019 | |
| Director/Board Member | 36 | 01/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.33% | -1.26% | +18.00% | +244.07% | 72Cr | |
| +0.57% | +1.33% | +57.02% | +127.62% | 1,14300Cr | |
| +0.86% | +5.02% | +44.82% | +84.12% | 65TCr | |
| +0.41% | +0.77% | +26.13% | +102.27% | 51TCr | |
| -0.05% | +1.73% | +52.74% | +65.27% | 38TCr | |
| -0.80% | -6.13% | +61.66% | +37.02% | 35TCr | |
| +0.34% | +1.84% | +30.70% | +52.69% | 29TCr | |
| -0.45% | +1.19% | +2.89% | +24.92% | 26TCr | |
| +0.45% | +2.57% | +53.93% | +70.83% | 24TCr | |
| +0.27% | +3.75% | +35.17% | +104.88% | 20TCr | |
| Average | +0.27% | +1.07% | +38.30% | +91.37% | 40.28TCr | |
| Weighted average by Cap. | +0.27% | +0.71% | +44.44% | +86.92% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 993.5Cr 10Cr 9.36Cr 8.65Cr 7.84Cr 15Cr 15Cr 103.46Cr 41Cr 519.88Cr 39Cr 38Cr 1.65TCr | 1.24TCr 13Cr 12Cr 11Cr 9.8Cr 18Cr 19Cr 129.31Cr 52Cr 649.81Cr 49Cr 48Cr 2.06TCr |
| Net income | 237.2Cr 2.49Cr 2.23Cr 2.07Cr 1.87Cr 3.5Cr 3.54Cr 25Cr 9.84Cr 124.12Cr 9.35Cr 9.15Cr 394.04Cr | 312.2Cr 3.28Cr 2.94Cr 2.72Cr 2.46Cr 4.6Cr 4.66Cr 33Cr 13Cr 163.37Cr 12Cr 12Cr 518.63Cr |
| Net Debt | - | - |
Employees
607
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/26/28 | ₹862.25 | +1.33% | 1,99,541 |
| 27/26/27 | ₹850.90 | +2.14% | 91,955 |
| 26/26/26 | ₹833.05 | +1.77% | 90,442 |
| 23/26/23 | ₹818.55 | -2.12% | 1,62,923 |
| 22/26/22 | ₹836.25 | -0.75% | 1,12,881 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SUPRIYA Stock
Select your edition
All financial news and data tailored to specific country editions
